QS should be available for women in the United States.
Reason for the survey: To gather evidence to gain FDA approval for QS permanent contraception for women a safe and 98% effective method.
Why should I take this survey: To help U.S. women who wish to have no more children end their fertility without surgery.
How long will this survey take: Approximately 15 minutes.
How will I be compensated: Please specify and/or 501(C)3 nonprofit ISAF will email you a letter thanking you for your donation.
Background:
Watch our best video (turn off VPN and use the back button to return) and read about this safe and 98% effective non-drug in-office method.
The QS procedure – is a nonsurgical permanent contraceptive method for women. Using an intrauterine device (IUD) inserter a trained healthcare provider puts 7 tiny (36mg) quinacrine pellets into the uterus without need for general anesthesia twice. The 1st dose is given after a period ends. The 2nd dose is given one month later. The patient can return to work after each 1 hour visit and must keep using their old birth control method for the next 3 months while an immune response to the quinacrine pellets permanently blocks both fallopian tubes 98% of the time (not 99% like having your tubes tied). Blockage can be verified by ultrasound. You can read our QS FDA Approved Phase 3 Trial Protocol on Amazon and free here. This method is safe and has been used by more than 200,000 women in over 50 countries with minimal side effects lasting a day or less. Our book of clinical trials on Amazon and free here shows:
- QS is safer than surgical tubal ligation.
- QS is as safe and effective as an intrauterine device (IUD).
- We’ve conducted 2 successful FDA Phase 1 trials and published scores of peer reviewed papers.
- FDA halted our QS Phase 3 trial in 2006 based on a study which killed 1/3 of the rats after giving them 60 to 83 times the dose women receive.
- Criteria to resume the trial was met in 2016 but FDA still to this day refuses to permit the trial.
- We proved that QS causes no more long-term risk of reproductive cancer than an IUD.
- We proved that QS causes no more long-term risk of hysterectomy or ectopic pregnancy than an IUD.
- QS causes no cancer in rats given less than 8 times the dosage given to women.
- QS causes no cancer in mice given less than 12 times the dosage given to women.
- Quinacrine’s Integrated Signature of Carcinogenicity (ISC) is less than the ISC of caffeine.
- Millions of adults took the oral dosage of quinacrine weekly, equal to the QS dosage, with no cancer.